Systemic mastocytosis
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Systemic mastocytosis is a blood disorder that can affect many different body systems. Individuals with the condition can develop signs and symptoms at any age, but it usually appears after adolescence.
Video picks for Genetic conditionsVideo library
Description
Systemic mastocytosis is a blood disorder that can affect many different body systems. Individuals with the condition can develop signs and symptoms at any age, but it usually appears after adolescence.
Signs and symptoms of systemic mastocytosis often include extreme tiredness (fatigue), skin redness and warmth (flushing), nausea, abdominal pain, bloating, diarrhea, the backflow of stomach acids into the esophagus (gastroesophageal reflux), nasal congestion, shortness of breath, low blood pressure (hypotension), lightheadedness, and headache. Some affected individuals have attention or memory problems, anxiety, or depression. Many individuals with systemic mastocytosis develop a skin condition called urticaria pigmentosa, which is characterised by raised patches of brownish skin that sting or itch with contact or changes in temperature. Nearly half of individuals with systemic mastocytosis will experience severe allergic reactions (anaphylaxis).
There are five subtypes of systemic mastocytosis, which are differentiated by their severity and the signs and symptoms. The mildest forms of systemic mastocytosis are the indolent and smoldering types. Individuals with these types tend to have only the general signs and symptoms of systemic mastocytosis described above. Individuals with smoldering mastocytosis may have more organs affected and more severe features than those with indolent mastocytosis. The indolent type is the most common type of systemic mastocytosis.
The severe types include aggressive systemic mastocytosis, systemic mastocytosis with an associated hematologic neoplasm, and mast cell leukemia. These types are associated with a reduced life span, which varies among the types and affected individuals. In addition to the general signs and symptoms of systemic mastocytosis, these types typically involve impaired function of an organ, such as the liver, spleen, or lymph nodes. The organ dysfunction can result in an abnormal buildup of fluid in the abdominal cavity (ascites). Aggressive systemic mastocytosis is associated with a loss of bone tissue (osteoporosis and osteopenia) and multiple bone fractures. Systemic mastocytosis with an associated hematologic neoplasm and mast cell leukemia both involve blood cell disorders or blood cell cancer (leukemia). Mast cell leukemia is the rarest and most severe type of systemic mastocytosis.
Individuals with the milder forms of the condition generally have a normal or near normal life expectancy, while those with the more severe forms typically survive months or a few years after diagnosis.
Inheritance patterns
The source lists the following possible inheritance patterns: Not inherited. More than one pattern can apply in different cases.
Related genes
Other names
Mast cell disease, systemic
Mastocytosis, systemic
Systemic mast cell disease
Systemic mast-cell disease
Systemic mastocytoses
Systemic tissue mast cell disease
Patient picks for Genetic conditions

Allergies, blood and immune system
Mastocytosis and mast cell disorders
A mast cell is a type of white blood cell. There are several forms of mastocytosis. In one, there are too many mast cells in the body: in another the number of mast cells is normal but they are too active.
by Dr Laurence Knott

Allergies, blood and immune system
Systemic sclerosis
Systemic sclerosis is a type of scleroderma, which means hard skin. If you have scleroderma, you have areas of hardening of the skin. In systemic sclerosis, you can also get hardening of some of your internal organs. This stops them working normally. There are many possible symptoms and problems that may develop with systemic sclerosis because the extent of the disease can vary greatly from person to person. People with systemic sclerosis should have regular monitoring of blood pressure, blood and urine tests, and lung function, and should report any unexplained symptoms promptly to a doctor. Systemic sclerosis cannot be cured but there are various treatments which can help. Newer treatments have improved the outlook for this condition.
by Dr Colin Tidy, MRCGP

Allergies, blood and immune system
Lupus
Lupus is the short name for the condition called systemic lupus erythematosus (SLE). It can cause various symptoms, the most common being joint pains, skin rashes and tiredness. Problems with kidneys and other organs can occur in severe cases. Lupus is an autoimmune condition. Treatment includes anti-inflammatory painkillers to ease joint pains. An antimalarial, called hydroxychloroquine, can help to prevent flares. Steroids and/or other medication to control the immune system are sometimes also needed.
by Dr Doug McKechnie, MRCGP
Related patient information and medicines

Patient information leaflet
Mastocytosis and mast cell disorders
A mast cell is a type of white blood cell. Systemic mastocytosis This can cau... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new guidance on the use of midostaurin for people with mastocytosis. NICE recommends that.

Patient information leaflet
Joint pain
The medical word for joint pain is arthralgia. See the separate leaflet called ... Connective tissue diseases For example, conditions such as systemic lupus erythematosus and scleroderma: connective tissue diseases affect tissues throughout the body, including tendons, ligaments, skin, eyes, cartilage, bone and blood vessels. See the separate.

Patient information leaflet
Angio-oedema
Examples... Hives About half of people who have chronic urticaria also have regular episodes of angio-oedema. Systemic lupus erythematosus (SLE) Lupus. Thyroiditis (hypothyroidism) Underactive thyroid gland. Allergic reactions Some people develop angio-oedema as part of an allergic reaction Allergies. In some cases this is due to a type of cancer.

Patient information leaflet
Pericarditis
Pericarditis is inflammation of the pericardium, which is the sac which surrounds and helps to protect the heart. Pericarditis typically causes chest pain as its main symptom. For ... Inflammatory diseases which can affect various parts of the body may include inflammation of the pericardium - for example, rheumatoid arthritis Rheumatoid arthritis.

Patient information leaflet
Skin rashes
There are many different types of skin rashes and many different causes of skin rashes. Although most skin rashes are harmless, some do need treatme... Some rashes ( especially dark red or purple rashes that don't fade when you press them ) may even need urgent medical treatment as they can be associated with meningitis and blood infection.

Patient information leaflet
Salivary gland disorders
... All tumours need investigation, however, and most are removed with an operation. Illness of other body systems A generalised swelling of salivary glands can be caused by illness of other body systems (systemic illness). The most common of these is a condition called Sjögren's syndrome, Sjögren's syndrome which results in you having a very dry.
Further reading and references
- Systemic mastocytosis; MedlinePlus, National Library of Medicine.
- Akin C, Valent P. Diagnostic criteria and classification of mastocytosis in 2014. Immunol Allergy Clin North Am. 2014 May;34(2):207-18. doi: 10.1016/j.iac.2014.02.003.
- Bonadonna P, Pagani M, Aberer W, Bilo MB, Brockow K, Oude Elberink H, Garvey L, Mosbech H, Romano A, Zanotti R, Torres MJ. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Allergy. 2015 Jul;70(7):755-63. doi: 10.1111/all.12617. Epub 2015 Apr 24.
- Castells MC. Mastocytosis: Moving the Field to Precision and Personalized Medicine. Immunol Allergy Clin North Am. 2018 Aug;38(3):xv-xvii. doi: 10.1016/j.iac.2018.05.001. Epub 2018 Jun 9. No abstract available.
- Scherber RM, Borate U. How we diagnose and treat systemic mastocytosis in adults. Br J Haematol. 2018 Jan;180(1):11-23. doi: 10.1111/bjh.14967. Epub 2017 Oct 19.
- Tremblay D, Carreau N, Kremyanskaya M, Mascarenhas J. Systemic Mastocytosis: Clinical Update and Future Directions. Clin Lymphoma Myeloma Leuk. 2015 Dec;15(12):728-38. doi: 10.1016/j.clml.2015.07.644. Epub 2015 Aug 5.
- Valent P, Aberer E, Beham-Schmid C, Fellinger C, Fuchs W, Gleixner KV, Greul R, Hadzijusufovic E, Hoermann G, Sperr WR, Wimazal F, Wohrl S, Zahel B, Pehamberger H. Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM). Am J Blood Res. 2013 May 5;3(2):174-80. Print 2013.
- Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017 Mar 16;129(11):1420-1427. doi: 10.1182/blood-2016-09-731893. Epub 2016 Dec 28.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

